ICAM5 as a novel target for treating cognitive impairment in Fragile X Syndrome

Published: 2020-02-05

DOI: 10.1523/jneurosci.2626-18.2019

Affiliations: 8

Authors: 17

Institutions	Authors	Share
Brain Science and Advanced Technology Institute, WUST, China		0.28
Hubei Provincial Key Laboratory of Occupational Hazard Identification and Control, WUST, China		0.28
Big Data Science and Engineering Research Institute, WUST, China		0.24
MOE Key Laboratory for Neurological Disorders, HUST, China		0.06
Department of Pathophysiology, HUST, China		0.06
MOE Laboratory of Neuroscience, PUHSC PKU, China		0.03
Department of Neurobiology, PKU, China		0.03
Department of Psychiatry, UT Southwestern Medical Center, United States of America (USA)		0.02

Return

Latest supplement

Nature Index 2020 South Korea

A concerted government push to make South Korea an innovation leader, backed by strong investment and systemic reform, has brought rapid and long-lasting results. The country’s scientific landscape is becoming more diverse and more productive, as a place where upwardly mobile researchers thrive.

Access free